Suprepharmagroup Tirzepatide 20mg/60mg Supplier Wholesale GMP Peptide API for Global Research

Suprepharmagroup Tirzepatide 20mg/60mg Supplier Wholesale GMP Peptide API for Global Research

Suprepharmagroup Tirzepatide 20mg/60mg Supplier Wholesale GMP peptide API for metabolic research and pharmaceutical development. High-purity raw material, global export to Europe and North America, reliable peptide manufacturer and bulk supply partner.

Tirzepatide is a long-acting synthetic peptide dual agonist targeting GIP and GLP-1 receptors. As a breakthrough incretin-based therapy molecule, it has demonstrated significant clinical efficacy in metabolic disease research, especially obesity and type 2 diabetes management.

What is Tirzepatide?

Tirzepatide (CAS No. 2023788-19-2) is a once-weekly injectable peptide acting as a dual GIP and GLP-1 receptor agonist. It enhances insulin secretion, reduces glucagon levels, slows gastric emptying, and promotes weight reduction through appetite regulation.

It is internationally recognized under the brand name Mounjaro for type 2 diabetes and Zepbound for chronic weight management in regulated markets.

Tirzepatide 20mg / 60mg Chemical Properties

Product Name: Tirzepatide

Strength: 20 mg / 60 mg

CAS Number: 2023788-19-2

Molecular Type: Synthetic long-acting peptide

Mechanism: Dual GIP / GLP-1 receptor agonist

Solubility: Water-soluble peptide

Stability: Requires cold-chain storage (2–8°C)

Grade: GMP / Research grade available

The peptide structure incorporates fatty-acid side chain modification to prolong half-life and enhance receptor affinity, making it suitable for advanced clinical research and pharmaceutical formulation development.

Indications & Research Applications

Tirzepatide is widely studied for:

Type 2 Diabetes Mellitus (T2DM)

Chronic weight management

Obesity treatment

Cardiometabolic risk reduction

Insulin resistance improvement

Clinical trials have shown substantial HbA1c reduction and significant body weight loss compared to traditional GLP-1 receptor agonists.

Suprepharmagroup – GMP Tirzepatide Supplier & Wholesale Partner

Suprepharmagroup is a professional peptide API supplier and wholesale provider, offering:

GMP-compliant production facilities

High purity peptide raw material

COA, MSDS, QC documentation support

Bulk wholesale packaging options

Cold-chain global logistics

Export coverage: Europe, North America, Asia-Pacific

As a reliable raw material supplier, we support pharmaceutical companies, research institutes, and biotech developers with stable supply and scalable production.

Research & Clinical Literature References

Key clinical research publications include:

SURPASS Clinical Trial Program – Evaluation of Tirzepatide in T2DM

SURMOUNT-1 Trial – Tirzepatide for obesity treatment

Dual GIP/GLP-1 receptor agonism mechanisms in metabolic regulation – peer-reviewed endocrinology journals

Researchers may consult databases such as PubMed using keywords:

“Tirzepatide dual agonist”

“SURPASS trial tirzepatide”

“SURMOUNT obesity study”

“GIP GLP-1 peptide therapy”

Why Choose Suprepharmagroup Tirzepatide Wholesale Supply?

✔ GMP Quality Assurance

✔ Stable bulk supply chain

✔ Competitive wholesale pricing

✔ International export documentation

✔ Professional peptide manufacturing expertise

✔ Support for Europe & North America markets

Compliance Notice

This product is supplied strictly for research and pharmaceutical development purposes in accordance with local regulations. Availability may vary depending on regulatory framework.